临床普外科电子杂志 ›› 2025, Vol. 13 ›› Issue (1): 50-.

• • 上一篇    下一篇

甲苯磺酸瑞马唑仑应用于行内镜逆行胰胆管造影术老年患者麻醉的临床观察

  

  1. 宿迁市沭阳仁慈医院 麻醉科,江苏 宿迁 223600
  • 出版日期:2025-01-01 发布日期:2025-03-24

Clinical observation of remifentanil tosylate used for anesthesia in elderly patients undergoing endoscopic retrograde cholangiopancreatography

  1. Anesthesiology Department of Shuyang Mercy Hospital in Suqian City, Jiangsu Suqian 223600, China
  • Online:2025-01-01 Published:2025-03-24

摘要:

目的 研究甲苯磺酸瑞马唑仑对经内镜逆行胰胆管造影术老年患者的麻醉效果。方法 选择2021 年 1 月至 2024 年 6 月宿迁市沭阳仁慈医院收治的 80 例老年经内镜逆行胰胆管造影术患者,按照随机数字表法分组,对照组(n=40)实施丙泊酚和舒芬太尼进行联合麻醉,观察组(n=40)实施瑞马唑仑联合舒芬太尼进行联合麻醉。对比两组患者手术相关指标,不同时刻下血流动力学指标,手术前后炎症因子水平、疼痛评分、生活质量评分,以及不良事件发生率。结果 两组患者手术时间、术中出血量、结石完全清除率对比无显著差异(P > 0.05),但观察组患者术中体动次数少于对照组,术后清醒时间短于对照组,差异均有显著性(P < 0.001)。麻醉前、术后清醒时,两组患者心率、平均动脉压、血氧饱和度对比无显著差异(P> 0.05)。进镜时、进镜后 10min,观察组患者的心率、平均动脉压、血氧饱和度均高于对照组,差异均有显著性(P < 0.05)。术前,两组患者炎症因子水平、疼痛评分、生活质量评分对比均无显著差异(P > 0.05)。术后,观察组患者的肿瘤坏死因子 -α 及白介素 -6 水平低于对照组,疼痛评分低于对照组,生活质量评分高于对照组,差异均有显著性(P < 0.001)。观察组患者不良反应发生率显著低于对照组患者(5.00% 比25.00%;χ2=6.275,P=0.012)。结论 经内镜逆行胰胆管造影术老年患者采用甲苯磺酸瑞马唑仑麻醉,可提升麻醉效果,术后疼痛程度更低,生活质量以及安全性更高。

关键词: 甲苯磺酸瑞马唑仑, 内镜逆行胰胆管造影术, 老年, 麻醉

Abstract:

Objective To investigate the anesthetic eff ect of remifentanil tosylate on elderly patients under- going endoscopic retrograde cholangiopancreatography. Method Eighty elderly patients undergoing endoscopic retrograde cholangiopancreatography admitted to Shuyang Mercy Hospital in Suqian City from January 2021 to June 2024 were randomly divided into two groups using a random number table. The control group (n=40) received combined anesthesia with propofol and sufentanil, while the observation group (n=40) received combined anesthe-sia with remifentanil and sufentanil. Compare surgical related indicators, hemodynamic parameters at diff erent time points, levels of infl ammatory factors before and after surgery, pain scores, quality of life scores, and incidence of adverse events between two groups of patients. Result There was no signifi cant diff erence in surgical time, intra-operative blood loss, and complete stone clearance rate between the two groups of patients (P > 0.05), but the observation group had fewer body movements during surgery and shorter postoperative recovery time than the control group, with signifi cant diff erences (P < 0.001). There was no signifi cant diff erence (P > 0.05) in heart rate, mean arterial pressure, and blood oxygen saturation between the two groups of patients before anesthesia and when awake after surgery. At the time of insertion and 10 minutes after insertion, the heart rate, mean arterial pressure, and blood oxygen saturation of the observation group were signifi cantly higher than those of the control group (P < 0.05). Before surgery, there was no signifi cant diff erence in the levels of infl ammatory factors, pain scores, and quality of life scores between the two groups of patients (P > 0.05). After surgery, the levels of tumor necrosis factor-α and interleukin-6 in the observation group were lower than those in the control group, the pain score was lower than that in the control group, and the quality of life score was higher than that in the control group, with signifi cant diff er-ences (P < 0.001). The incidence of adverse reactions in the observation group was signifi cantly lower than that in

the control group (5.00% vs. 25.00%; χ2=6.275, P=0.012). Conclusion The use of remifentanil tosylate anesthesia in elderly patients undergoing endoscopic retrograde cholangiopancreatography can improve anesthesia eff ective-ness, reduce postoperative pain, improve quality of life, and increase safety.

Key words: Rimazolen tosylate, Endoscopic retrograde cholangiopancreatography, Elderly, Anaesthesia